skip to main content
Idioma:
Refinado por: assunto: Disease-Free Survival remover assunto: Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

Sacchi, Stefano ; Marcheselli, Raffaella ; Bari, Alessia ; Buda, Gabriele ; Molinari, Anna Lia ; Baldini, Luca ; Vallisa, Daniele ; Cesaretti, Marina ; Musto, Pellegrino ; Ronconi, Sonia ; Specchia, Giorgina ; Silvestris, Franco ; Guardigni, Luciano ; Ferrari, Angela ; Chiapella, Annalisa ; Carella, Angelo Michele ; Santoro, Armando ; Di Raimondo, Francesco ; Marcheselli, Luigi ; Pozzi, Samantha

Haematologica (Roma), 2016-05, Vol.101 (5), p.e196-e199 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
2
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Cavo, Michele, Prof ; Tacchetti, Paola, MD ; Patriarca, Francesca, MD ; Petrucci, Maria Teresa, MD ; Pantani, Lucia, MD ; Galli, Monica, MD ; Di Raimondo, Francesco, Prof ; Crippa, Claudia, MD ; Zamagni, Elena, MD ; Palumbo, Antonio, MD ; Offidani, Massimo, MD ; Corradini, Paolo, Prof ; Narni, Franco, MD ; Spadano, Antonio, MD ; Pescosta, Norbert, MD ; Deliliers, Giorgio Lambertenghi, Prof ; Ledda, Antonio, MD ; Cellini, Claudia, MD ; Caravita, Tommaso, MD ; Tosi, Patrizia, MD ; Baccarani, Michele, Prof

The Lancet (British edition), 2010-12, Vol.376 (9758), p.2075-2085 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Cavo, Michele ; Pantani, Lucia ; Petrucci, Maria Teresa ; Patriarca, Francesca ; Zamagni, Elena ; Donnarumma, Daniela ; Crippa, Claudia ; Boccadoro, Mario ; Perrone, Giulia ; Falcone, Antonietta ; Nozzoli, Chiara ; Zambello, Renato ; Masini, Luciano ; Furlan, Anna ; Brioli, Annamaria ; Derudas, Daniele ; Ballanti, Stelvio ; Dessanti, Maria Laura ; De Stefano, Valerio ; Carella, Angelo Michele ; Marcatti, Magda ; Nozza, Andrea ; Ferrara, Felicetto ; Callea, Vincenzo ; Califano, Catello ; Pezzi, Annalisa ; Baraldi, Anna ; Grasso, Mariella ; Musto, Pellegrino ; Palumbo, Antonio

Blood, 2012-07, Vol.120 (1), p.9-19 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

CAVO, M ; BANDINI, G ; MOTTA, M ; RIZZI, S ; TURA, S ; BENNI, M ; GOZZETTI, A ; RONCONI, S ; ROSTI, G ; ZAMAGNI, E ; LEMOLI, R ; BONINI, A ; BELARDINELLI, A

Bone marrow transplantation (Basingstoke), 1998-07, Vol.22 (1), p.27-32 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy

ZINZANI, P. L ; MARTELLI, M ; GHERLINZONI, F ; MORETTI, L ; DE RENZO, A ; MAZZA, P ; PAVONE, E ; SABATTINI, E ; AMENDOLA, A ; BENDANDI, M ; PILERI, S. A ; MANDELLI, F ; MAGAGNOLI, M ; TURA, S ; ZACCARIA, A ; RONCONI, F ; CANTONETTI, M ; BOCCHIA, M ; MARRA, R ; GOBBI, M ; FALINI, B

Blood, 1998-08, Vol.92 (3), p.790-794 [Periódico revisado por pares]

Washington, DC: The Americain Society of Hematology

Texto completo disponível

Citações Citado por
6
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy

Lemoli, Roberto M. ; Martinelli, Giovanni ; Zamagni, Elena ; Motta, Maria Rosa ; Rizzi, Simonetta ; Terragna, Carolina ; Rondelli, Roberto ; Ronconi, Sonia ; Curti, Antonio ; Bonifazi, Francesca ; Tura, Sante ; Cavo, Michele

Blood, 2000-04, Vol.95 (7), p.2234-2239 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1998  (1)
  2. 1998Até1999  (2)
  3. 2000Até2009  (1)
  4. 2010Até2012  (2)
  5. Após 2012  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.